Related Experiment Video
Updated: Jun 14, 2026

Du-Moxibustion in a Mouse Model of Ankylosing Spondylitis
Published on: October 27, 2023
Atherosclerosis and endothelial dysfunction in patients with ankylosing spondylitis
1Head of Spondylarthropathies Service, Federal University of Paraná, Rua Lamenha Lins 1110 ap 11A, Rebouças-Curitiba, PR, 80250-020, Brazil. valderilio@hotmail.com
Ankylosing spondylitis patients face higher cardiovascular risks due to endothelial dysfunction and atherosclerosis. This review examines these factors and current assessment challenges in ankylosing spondylitis (AS).
Area of Science:
- Rheumatology
- Cardiology
- Pathology
Background:
- Ankylosing spondylitis (AS) is a systemic inflammatory disease affecting joints.
- Elevated cardiovascular mortality is observed in AS patients.
- Endothelial dysfunction and atherosclerosis are potential contributors to cardiovascular risk in AS.
Purpose of the Study:
- To review existing literature on endothelial dysfunction and atherosclerosis in AS patients.
- To discuss challenges in assessing these cardiovascular risk factors in AS.
Main Methods:
- Literature review of published data.
- Synthesis of information on endothelial function and atherosclerosis in AS.
Main Results:
- AS is associated with endothelial dysfunction.
- Atherosclerosis is a concern in AS patients.
- Current assessment methods for these conditions in AS have limitations.
Conclusions:
- Endothelial dysfunction and atherosclerosis are significant concerns in AS.
- Further research is needed to improve the assessment of cardiovascular risk in AS.
Related Concept Videos
Atherosclerosis I: Introduction
Peripheral Artery Disease I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis IV: Nursing Management
Coronary Artery Disease II: Pathophysiology
Rheumatic Heart Disease I: Introduction